| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |